Summary: A leading figure in molecular psychiatry shares how curiosity about DNA led to a career focused on unraveling the biological roots of neurodevelopmental conditions like ADHD. By bridging genetics, neuroscience, and psychiatry, their work has illuminated how variations in DNA and environmental influences shape brain development and behavior.

Using models from fruit flies to stem cells and leveraging data science, they aim to develop more precise and personalized mental health treatments. Their recent focus on epigenetics explores how life experiences can modify gene activity, offering new paths for early detection and prevention in psychiatric disorders.

Key Facts:

  • Genetic Foundations: DNA variations play a key role in shaping brain function and behavior.
  • Environmental Impact: Epigenetic research reveals how life experiences can alter gene expression and influence mental health.
  • Next-Gen Psychiatry: Integrating molecular tools and data science opens doors to personalized treatment strategies.

Source: Genomic Press

In a comprehensive Genomic Press interview published today, Professor Barbara Franke unveils her remarkable scientific journey from an inquisitive child fascinated by nature to becoming one of the world’s most influential researchers in biological psychiatry.

The molecular psychiatrist at Radboud University has fundamentally transformed our understanding of how genetic variations lead to altered behavior in neurodevelopmental conditions, particularly ADHD.

From HeLa Cells to Human Behavior

Professor Franke’s career trajectory took an unexpected turn during a practical session isolating DNA from HeLa cells.

“I fell in love with molecular genetics,” she recalls, describing how this pivotal moment shifted her focus from studying great apes in Africa to unraveling the molecular mysteries of human behavior.

This transition ultimately led her to psychiatric genetics, where she found her true calling in addressing the controversial and misunderstood nature of ADHD.

With over 500 peer-reviewed publications, Professor Franke has established herself among the top 1% most cited scientists globally. Her work extends far beyond traditional gene identification, employing innovative approaches that bridge multiple scientific disciplines.

“I am absolutely amazed at how much we can already learn about the biological pathways and brain-cellular substrates underlying psychiatric conditions using data science methods,” she notes, while emphasizing the indispensable role of experimental validation.

Building Bridges Across Disciplines

Professor Franke’s leadership in founding multiple international research consortia, including the International Multicentre persistent ADHD Collaboration (IMpACT) and the ECNP Network ADHD across the lifespan, demonstrates her commitment to collaborative science. As a founding member of the Psychiatric Genomics Consortium (PGC), she recognized early that advancing psychiatric genetics required unprecedented international cooperation.

Her research philosophy combines cutting-edge bioinformatics with experimental models ranging from fruit flies to human induced pluripotent stem cells. This multifaceted approach raises intriguing questions about how genetic variations translate into behavioral differences and whether understanding these mechanisms could lead to more personalized treatments for neurodevelopmental conditions.

A New Vision for Psychiatric Classification

Currently heading the Medical Neuroscience department at Radboud University Medical Center, Professor Franke harbors ambitious goals. “We still need a new nosology in psychiatry, and I want to contribute to that by identifying genes and pathways,” she explains.

Her recent venture into epigenetics research explores how environmental factors interact with genetic predispositions, potentially unlocking new avenues for prevention and intervention strategies.

The decorated Knight in the Order of the Netherlands Lion approaches her work with a philosophy captured by the German proverb she lives by: “Die Suppe wird nicht so heiß gegessen, wie sie gekocht wird” (“The soup is not eaten as hot as it is cooked”). This balanced perspective has enabled her to navigate complex scientific challenges while mentoring the next generation of researchers.

Impact Beyond the Laboratory

Professor Franke’s influence extends beyond her scientific contributions. Her “jump first, think later” mentorship approach has empowered countless young scientists, particularly women, to seize opportunities in competitive research environments. This philosophy raises important questions about how scientific culture might evolve if more researchers embraced calculated risk-taking and rapid decision-making.

The interview reveals fascinating insights into Professor Franke’s recent move to epigenetics, using advanced single-cell resolution techniques to study DNA modifications and transcriptomes. These cutting-edge approaches could potentially identify biomarkers for treatment response or reveal critical windows for intervention during brain development.

As psychiatric conditions continue to affect millions worldwide, Professor Franke’s work offers hope for improved diagnosis and treatment. Her integration of molecular biology, neuroscience, and clinical psychiatry exemplifies the interdisciplinary approach needed to tackle complex brain disorders.

The question remains: How quickly can these biological insights translate into tangible improvements in patient care?

About this genetics and ADHD research news

Author: Ma-Li Wong
Source: Genomic Press
Contact: Ma-Li Wong – Genomic Press
Image: The image is credited to Neuroscience News

Original Research: Open access.
Understanding the biological pathways from genes to altered behaviour in neurodevelopmental conditions like ADHD – paving the way for improved understanding and care in psychiatry” by Barbara Franke et al. Genomic Psychiatry

Abstract

Understanding the biological pathways from genes to altered behaviour in neurodevelopmental conditions like ADHD – paving the way for improved understanding and care in psychiatry

In this Genomic Press Interview, Professor Barbara Franke, a trailblazing molecular psychiatrist at Radboud University in Nijmegen, shares her extraordinary scientific journey from an inquisitive child fascinated by nature to becoming one of the world’s most influential researchers in biological psychiatry.

With over 500 peer-reviewed publications and recognition among the top 1% most cited scientists globally, Franke has helped to revolutionize our understanding of the genetic foundations of neurodevelopmental disorders, particularly ADHD.

Bringing together international experts for interdisciplinary research, she founded and leads multiple international research consortia, including the International Multicentre persistent ADHD Collaboration (IMpACT) and the ECNP Network ADHD across the lifespan.

Her pioneering work extends beyond gene identification to illuminating the biological pathways from genetic variations to altered behaviour, employing innovative complementary approaches including bioinformatics, brain imaging genetics, and experimental models using fruit flies and human induced pluripotent stem cells.

An elected member of the Royal Netherlands Academy of Arts and Sciences, decorated Knight in the Order of the Netherlands Lion, and recipient of numerous prestigious awards, Franke’s scientific contributions are matched by her passionate commitment to international collaboration and mentorship of the next generation of researchers.

Her recent move into epigenetics research, investigating the interplay between heritable and environmental influences on psychiatric conditions, illustrates her unwavering determination to contribute to a new nosology in psychiatry that will ultimately improve diagnosis, treatment, and management for millions worldwide.

Guided by the German proverb “Die Suppe wird nicht so heiß gegessen, wie sie gekocht wird” (“The soup is not eaten as hot as it is cooked”), Franke’s balanced approach to life and science continues to inspire groundbreaking advances at the intersection of genetics, neuroscience, and psychiatry.